Rise of the patient affairs officer; Sanofi makes appointment
This article was originally published in Scrip
Following the growing trend of pharmaceutical companies embracing patient-centric business models, Sanofi has appointed Dr Anne C Beal chief of patient affairs. The French pharma is the first of the top ten biopharmaceutical companies to create space for such a position, according to Pascale Witz executive vice-president of global and strategic development.
You may also be interested in...
UCB's recently appointed head of corporate strategy and business development Alexander Moscho, who joined the company in October 2017, talks to Scrip about UCB's future growth, internal R&D pipeline and potential for significant deal-making in 2018.
Julie Adrian, European managing director of inVentiv Health Communications, outlines the greatest barriers preventing companies from engaging patients earlier in drug development and highlights the greatest benefits on offer to those that can successfully implement patient-centric drug discovery models.
A rush in the 2010s of high-tech and digital companies focused on women’s health and wellbeing are maturing, adding weight to the more traditional women's health market that has struggled to get attention from investors in the past.